Published in Carcinogenesis on February 01, 2000
Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci (2008) 4.24
Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy. J Nanobiotechnology (2007) 2.93
Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator. Blood (2008) 1.97
Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Cancer Epidemiol Biomarkers Prev (2008) 1.85
Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Res Treat (2009) 1.77
Curcumin stimulates proliferation of embryonic neural progenitor cells and neurogenesis in the adult hippocampus. J Biol Chem (2008) 1.55
Prebiotics: A Novel Approach to Treat Hepatocellular Carcinoma. Can J Gastroenterol Hepatol (2017) 1.39
Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges. Curr Cancer Drug Targets (2012) 1.23
Curcumin enhances the efficacy of chemotherapy by tailoring p65NFκB-p300 cross-talk in favor of p53-p300 in breast cancer. J Biol Chem (2011) 1.04
Anti-Obesity and Anti-Diabetic Effects of Acacia Polyphenol in Obese Diabetic KKAy Mice Fed High-Fat Diet. Evid Based Complement Alternat Med (2011) 0.99
Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy. Int J Nanomedicine (2012) 0.92
Herbal medicine and hepatocellular carcinoma: applications and challenges. Evid Based Complement Alternat Med (2011) 0.92
Therapeutic potential of curcumin in gastrointestinal diseases. World J Gastrointest Pathophysiol (2011) 0.91
Targeting the inflammation in HCV-associated hepatocellular carcinoma: a role in the prevention and treatment. J Transl Med (2010) 0.88
Curcumin reduces the toxic effects of iron loading in rat liver epithelial cells. Liver Int (2008) 0.86
Folic acid conjugated cross-linked acrylic polymer (FA-CLAP) hydrogel for site specific delivery of hydrophobic drugs to cancer cells. J Nanobiotechnology (2014) 0.85
Chemotherapeutic potential of curcumin-bearing microcells against hepatocellular carcinoma in model animals. Int J Nanomedicine (2014) 0.84
Overexpression of the ATP binding cassette gene ABCA1 determines resistance to Curcumin in M14 melanoma cells. Mol Cancer (2009) 0.84
Assessment of hemodynamics in a rat model of liver cirrhosis with precancerous lesions using multislice spiral CT perfusion imaging. Biomed Res Int (2013) 0.83
Modulatory effect of curcumin on survival of irradiated human intestinal microvascular endothelial cells: role of Akt/mTOR and NF-{kappa}B. Am J Physiol Gastrointest Liver Physiol (2010) 0.83
Hexahydrocurcumin enhances inhibitory effect of 5-fluorouracil on HT-29 human colon cancer cells. World J Gastroenterol (2012) 0.82
Effects of curcumin on global gene expression profiles in the highly invasive human breast carcinoma cell line MDA-MB 231: A gene network-based microarray analysis. Exp Ther Med (2012) 0.79
Proteasome inhibitors, including curcumin, improve pancreatic β-cell function and insulin sensitivity in diabetic mice. Nutr Diabetes (2016) 0.79
Null anticarcinogenic effect of silymarin on diethylnitrosamine-induced hepatocarcinogenesis in rats. Exp Ther Med (2013) 0.78
Curcumin improves liver damage in male mice exposed to nicotine. J Tradit Complement Med (2015) 0.78
Curcuma Contra Cancer? Curcumin and Hodgkin's Lymphoma. Cancer Growth Metastasis (2013) 0.78
Effect of antioxidant phytochemicals on the hepatic tumor promoting activity of 3,3',4,4'-tetrachlorobiphenyl (PCB-77). Food Chem Toxicol (2008) 0.77
Mouse models of liver cancer: Progress and recommendations. Oncotarget (2015) 0.77
Bismuth nitrate-induced microwave-assisted expeditious synthesis of vanillin from curcumin. Org Med Chem Lett (2012) 0.76
Curcumin induces G2/M arrest and triggers apoptosis via FoxO1 signaling in U87 human glioma cells. Mol Med Rep (2016) 0.75
Oral or parenteral administration of curcumin does not prevent the growth of high-risk t(4;11) acute lymphoblastic leukemia cells engrafted into a NOD/SCID mouse model. Int J Oncol (2012) 0.75
Curcumin enhances the antitumor effect of ABT-737 via activation of the ROS-ASK1-JNK pathway in hepatocellular carcinoma cells. Mol Med Rep (2015) 0.75
Suppression of influenza virus infection by the orf virus isolated in Taiwan. J Vet Med Sci (2015) 0.75
Novel protective role of curcumin and taurine combination against experimental hepatocarcinogenesis. Exp Ther Med (2016) 0.75
Synergistic Interplay between Curcumin and Polyphenol-Rich Foods in the Mediterranean Diet: Therapeutic Prospects for Neurofibromatosis 1 Patients. Nutrients (2017) 0.75
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res (2001) 5.78
Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos (1999) 3.30
Increasing live donor kidney transplantation: a randomized controlled trial of a home-based educational intervention. Am J Transplant (2006) 3.11
Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal (1997) 2.77
Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998. Pediatr Infect Dis J (1999) 2.75
Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex. Mol Cell Biol (2000) 2.34
The antiapoptotic gene mcl-1 is up-regulated by the phosphatidylinositol 3-kinase/Akt signaling pathway through a transcription factor complex containing CREB. Mol Cell Biol (1999) 2.12
Analysis of 200 food items for benzo[a]pyrene and estimation of its intake in an epidemiologic study. Food Chem Toxicol (2001) 2.12
Rapidly fatal outcome of bacteremic Klebsiella pneumoniae pneumonia in alcoholics. Chest (1995) 2.02
Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis. J Cell Physiol (1998) 1.95
Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy. Int J Radiat Oncol Biol Phys (2000) 1.89
2,3-Dihydro-2-(guan-7-yl)-3-hydroxy-aflatoxin B1, a major acid hydrolysis product of aflatoxin B1-DNA or -ribosomal RNA adducts formed in hepatic microsome-mediated reactions and in rat liver in vivo. Cancer Res (1977) 1.88
Functional association of essential splicing factor(s) with PRP19 in a protein complex. EMBO J (1994) 1.86
Ultrastructural localization and progressive formation of neuropil aggregates in Huntington's disease transgenic mice. Hum Mol Genet (1999) 1.86
Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future clinical trials. Int J Radiat Oncol Biol Phys (2001) 1.76
Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience. Jpn J Clin Oncol (2000) 1.74
The proneural gene amos promotes multiple dendritic neuron formation in the Drosophila peripheral nervous system. Neuron (2000) 1.74
Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol. Br J Pharmacol (1999) 1.72
Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells. Eur J Cancer (1999) 1.68
Aflatoxin B1-2,3-oxide as a probable intermediate in the covalent binding of aflatoxins B1 and B2 to rat liver DNA and ribosomal RNA in vivo. Cancer Res (1977) 1.67
Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis (1999) 1.67
Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway. Oncogene (2006) 1.66
Human papillomavirus and cervical neoplasia: a case-control study in Taiwan. Int J Cancer (1995) 1.66
Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum (II) in human ovarian cancer cell lines. Cancer Res (1988) 1.55
(-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB. Mol Pharmacol (1997) 1.55
Association of CTLA4 gene A-G polymorphism with type 1 diabetes in Chinese children. Clin Endocrinol (Oxf) (2000) 1.54
Local thermal stimulation relaxes hypertonic anal sphincter: evidence of somatoanal reflex. Dis Colon Rectum (1999) 1.54
Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. Proc Natl Acad Sci U S A (1991) 1.53
Site-specific phosphorylation regulates the transcriptive activity of vesicular stomatitis virus NS protein. J Virol (1982) 1.53
mcl-1 is an immediate-early gene activated by the granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling pathway and is one component of the GM-CSF viability response. Mol Cell Biol (1998) 1.53
Prenatal and neonatal intussusception. Pediatr Surg Int (1998) 1.50
Chromophoric labeling of amino acids with 4-dimethylaminoazobenzene-4'-sulfonyl chloride. Anal Chem (1975) 1.50
Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IkappaB kinase and NFkappaB activation in macrophages. Biochem Pharmacol (2000) 1.48
Do cerebral potentials to magnetic stimulation of paraspinal muscles reflect changes in palpable muscle spasm, low back pain, and activity scores? J Manipulative Physiol Ther (2000) 1.46
Acute segmental obstructing enteritis in children. J Pediatr Gastroenterol Nutr (1994) 1.46
DNA and amino acid sequence analysis of structural and immunity genes of colicins Ia and Ib. J Bacteriol (1986) 1.45
Preoperative ultrasound study in predicting lymph node metastasis for endometrial cancer patients. Gynecol Oncol (1998) 1.42
The role of blocking factors and antipaternal lymphocytotoxic antibodies in the success of pregnancy in patients with recurrent spontaneous abortion. Fertil Steril (1992) 1.41
Hepatitis B virus X protein inhibits transforming growth factor-beta -induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway. J Biol Chem (2000) 1.40
The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by up-regulation of Mcl-1 through a PI 3-K/Akt pathway. Oncogene (2001) 1.39
The effects of aqueous neutral-salt solutions on the melting temperatures of deoxyribonucleic acids. Biopolymers (1971) 1.39
Interleukin-6 inhibits transforming growth factor-beta-induced apoptosis through the phosphatidylinositol 3-kinase/Akt and signal transducers and activators of transcription 3 pathways. J Biol Chem (1999) 1.37
Bicarbonate hemodialysis: influence on plasma refilling and hemodynamic stability. Nephron (1984) 1.35
Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate. J Cell Biochem (1999) 1.34
Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. Biochim Biophys Acta (1996) 1.33
c-Met is a prognostic marker and potential therapeutic target in clear cell renal cell carcinoma. Ann Oncol (2012) 1.33
Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis. Blood (1991) 1.32
Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epidermoid carcinoma cells. J Cell Biochem (1997) 1.32
Identification of a doubly spliced viral transcript joining the separated domains for putative protease and reverse transcriptase of hepatitis B virus. J Virol (1989) 1.31
Cyclooxygenase-2 inducing Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1.0 cells. Involvement of phosphatidylinositol 3-kinase/Akt pathway. J Biol Chem (2001) 1.28
Presacral tumor: a review of forty-five cases. Am Surg (1995) 1.27
Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer. Br J Cancer (2004) 1.27
Constitutively phosphorylated residues in the NS protein of vesicular stomatitis virus. J Biol Chem (1985) 1.26
Interindividual differences in the concentration of 1-hydroxypyrene-glucuronide in urine and polycyclic aromatic hydrocarbon-DNA adducts in peripheral white blood cells after charbroiled beef consumption. Carcinogenesis (1995) 1.25
High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy. Br J Cancer (1997) 1.24
Overexpression of interleukin-6 in human basal cell carcinoma cell lines increases anti-apoptotic activity and tumorigenic potency. Oncogene (2001) 1.23
Unique features of breast cancer in Taiwan. Breast Cancer Res Treat (2000) 1.23
Curcumin induces a p53-dependent apoptosis in human basal cell carcinoma cells. J Invest Dermatol (1998) 1.21
Suppression of lipopolysaccharide-induced nuclear factor-kappaB activity by theaflavin-3,3'-digallate from black tea and other polyphenols through down-regulation of IkappaB kinase activity in macrophages. Biochem Pharmacol (2000) 1.20
Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator-activated receptor-gamma by flavonoids in mouse macrophages. FEBS Lett (2001) 1.20
Importance of early phase insulin secretion to intravenous glucose tolerance in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab (2001) 1.19
Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age. Br J Surg (2003) 1.19
Microbial iron respiration can protect steel from corrosion. Appl Environ Microbiol (2002) 1.18
NS phosphoprotein of vesicular stomatitis virus: subspecies separated by electrophoresis and isoelectric focusing. J Virol (1982) 1.14
Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines. Nutr Cancer (1996) 1.14
Cellular defects and altered gene expression in PC12 cells stably expressing mutant huntingtin. J Neurosci (1999) 1.13
Clinicopathological spectrum of haemophagocytic syndrome in Epstein-Barr virus-associated peripheral T-cell lymphoma. Br J Haematol (1994) 1.11
Trend of large bowel tuberculosis and the relation with pulmonary tuberculosis. Dis Colon Rectum (1992) 1.10
Hemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders: disease spectrum, pathogenesis, and management. Leuk Lymphoma (1995) 1.10
Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach. J Clin Oncol (2001) 1.10
Genetic heterogeneity in familial juvenile polyposis. Cancer Res (2000) 1.10
Hypermethylation of the p16 gene in sporadic T3N0M0 stage colorectal cancers: association with DNA replication error and shorter survival. Oncology (1999) 1.09
Griseofulvin potentiates antitumorigenesis effects of nocodazole through induction of apoptosis and G2/M cell cycle arrest in human colorectal cancer cells. Int J Cancer (2001) 1.08
Metaplastic carcinoma of the breast: analysis of eight Asian patients with special emphasis on two unusual cases presenting with inflammatory-type breast cancer. Anticancer Res (2000) 1.08
BCRP/MXR/ABCP expression in topotecan-resistant human breast carcinoma cells. Biochem Pharmacol (2000) 1.08
Interlaboratory agreement in a polymerase chain reaction-based human papillomavirus DNA assay. Cancer Epidemiol Biomarkers Prev (1996) 1.08
Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells. Br J Cancer (1999) 1.08
Weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of advanced gastric cancers. An effective and low-toxic regimen for patients with poor general condition. Oncology (1997) 1.07
CT findings of adrenal glands in patients with tuberculous Addison's disease. J Belge Radiol (1998) 1.06
Assembly of vesicular stomatitis virus nucleocapsids in vivo: a kinetic analysis. J Virol (1979) 1.06
Enterovesical fistula: 10 years experience. Zhonghua Yi Xue Za Zhi (Taipei) (1997) 1.06
High expression of thymidylate synthase is associated with the drug resistance of gastric carcinoma to high dose 5-fluorouracil-based systemic chemotherapy. Cancer (1998) 1.06
Urinary tract infection in febrile infants younger than eight weeks of Age. Pediatrics (2000) 1.05
Adult bacteremic pneumonia: bacteriology and prognostic factors. J Formos Med Assoc (1992) 1.05
Stabilizing effect of divalent metal ions on virions of southern bean mosaic virus. Virology (1976) 1.05
Cutaneous manifestations of postthymic T cell malignancies: description of five clinicopathologic subtypes. J Am Acad Dermatol (1990) 1.04
Occlusion of congenital ventricular septal defects by the buttoned device. "Buttoned device" Clinical Trials International Register. Heart (1997) 1.04
Feature extraction in carpal-bone analysis. IEEE Trans Med Imaging (1993) 1.04
Topography of phosphate residues in Sendai virus proteins. Virology (1982) 1.04
Genetic polymorphisms of p53 and GSTP1,but not NAT2,are associated with susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer (2000) 1.04
A prospective randomized three-week trial of spinal manipulation, transcutaneous muscle stimulation, massage and corset in the treatment of subacute low back pain. Spine (Phila Pa 1976) (1994) 1.04
Malignant thyroid teratoma of an adult: a long-term survival after chemotherapy. Am J Clin Oncol (1998) 1.03
A critical period for nicotine-induced disruption of synaptic development in rat auditory cortex. J Neurosci (2000) 1.03
Neonatal vallecular cyst: report of eleven cases. Changgeng Yi Xue Za Zhi (1999) 1.02